Which information should be included in the teaching plan for a client receiving glargine, a "peakless" basal insulin?

Bone densitometry, specifically Dual-Energy X-ray Absorptiometry (DEXA), is the clinical standard for measuring bone mineral density (BMD). It calculates a T-score by comparing the patient's bone mass to that of a healthy young adult. This non-invasive test is the most accurate predictor of fracture risk, particularly at the hip and lumbar spine where osteoporotic fractures are most debilitating.

A. Arthrography: This diagnostic imaging technique involves the injection of a radiopaque contrast agent into a joint space to visualize soft tissue structures like ligaments or menisci. It is primarily used to diagnose joint trauma or unexplained joint pain. It cannot evaluate calcium concentration within the bone matrix and therefore cannot assess for osteoporosis.

B. Bone scan: A bone scan uses a radioactive tracer to identify areas of increased metabolic activity, such as tumors, infections, or occult fractures. While it is highly sensitive for detecting "hot spots" of bone turnover, it does not provide a quantitative measure of bone thickness. It is not used for the routine screening or staging of systemic osteoporosis.

C. Arthroscopy: This is an invasive surgical procedure where a fiber-optic camera is inserted into a joint to allow for direct visualization of the articular surfaces. It is a diagnostic and therapeutic tool for internal derangements but does not provide data on the structural density of the skeletal system. It is irrelevant for assessing fracture risk associated with metabolic bone disease.

D. Bone densitometry: This test provides the specific numerical data required to diagnose osteopenia or osteoporosis according to World Health Organization criteria. By identifying low BMD before a fracture occurs, the care team can initiate pharmacological therapy with bisphosphonates. It is the only test listed that quantifies the actual strength of the bone tissue.

Osteomyelitis is an infection of the bone and marrow that typically occurs through hematogenous seeding or direct inoculation from an adjacent soft tissue ulcer. The structure of bone, with its microscopic channels, provides a sanctuary for bacteria to proliferate while remaining shielded from the immune system. The resulting inflammatory response causes increased intraosseous pressure, leading to bone necrosis and the formation of a sequestrum.

A. Escherichia coli: While this gram-negative bacillus can cause bone infections, it is typically associated with urinary tract sources or vertebral osteomyelitis in older adults. It is not the primary pathogen isolated from the majority of peripheral bone infections. Its presence usually suggests a secondary infection rather than the primary etiologic agent of a leg ulcer.

B. Pseudomonas: This opportunistic organism is frequently found in "puncture wound" osteomyelitis, particularly those involving the foot and rubber-soled shoes. It is known for its high resistance to multiple antibiotic classes and its ability to form protective biofilms. However, it remains less prevalent than the leading gram-positive cocci in general clinical cases.

C. Proteus: Members of the Proteus genus are occasionally isolated from polymicrobial infections, especially in chronic wounds with extensive tissue decay. They are known for their urease production, which can alter the local pH of the wound environment. Despite this, they are considered uncommon primary pathogens in the initial development of bone infection.

D. Staphylococcus aureus: This organism is the most frequent cause of osteomyelitis across all age groups due to its potent adhesion molecules that bind to bone matrix proteins. It possesses various virulence factors that allow it to invade bone cells and persist in a dormant state. It is isolated in up to 80% of cases involving direct bone contamination from skin ulcers.